**Medical Cannabis Reform Act

      This legislative bill will protect and strengthen RCW 69.51A by offering compassion, clarity and consistency through the following changes:

  • Bringing Washington state law into compliance with stated federal policy

  • Allowing business owners to obtain licenses for producing, processing or dispensing cannabis in a commercial manner. Using the language from ESSB 5073, specifying cannabis for medical use licensing, allowing producers and processors to deliver cannabis to any cannabis for medical use licensee, and allowing the botanical herb tax exemption on cannabis for medical use.

  • Creating and empowering the cannabis for medical use board, made up of the state and the community, to governor all aspects of the market. Through licensing and regulation fees, revenue is generated for the board to regulate the not-for-profit cannabis for medical use market while remaining revenue neutral.

  • Maintaining small, private residential gardens and patient cooperatives that do not violate the spirit or intent of law; as well as protecting existing cannabis farmer's markets serving qualifying patients.

  • Restoring reciprocity for non-residents and other protections passed by the Legislature in ESSB 5073.

  • Removing any instances of partially vetoed language. Reinstating essential definitions including cannabis, cannabis products, plant, etc., and correcting the spelling error of “useable”.

  • Adding Post-Traumatic Stress and Traumatic Brain Injury to the list of qualifying conditions, as well as addresses suitability of organ transplants to ensure that medical use of cannabis can no longer be the sole disqualifier for treatment.

  • Extending the same criminal and civil protections to qualifying patients that prescription drug patients receive.

  • Limiting housing discrimination for the medical use of cannabis.

  • Restricting employment-related cannabis test for qualifying patients.

  • Requiring video proof of impairment for qualifying patients.

  • Adding in protection to qualifying patient under 18 years of age, patients, legal guardians, and their designated providers.

  • Expanding the tetrahydrocannabinoidols control substance exemption to health care professionals, qualifying patients, designated providers, collective gardens, cannabis for medical use licensees, licensed testing facilities.

  • Limiting cooperation with federal investigations of authorized medical use of cannabis activities.


What makes this different from I-1372 is the section 1 written for Washington State:

     NEW SECTION. Sec. 1. (1) (a)Washington state voters spoke overwhelmingly in 1998, with the passage of Initiative Measure No. 692 creating cannabis for medical use by qualifying patients under chapter 69.51A RCW.

     (b) In 2003, the United States government, represented by the department health and human services, was granted a U.S. patent # 6630507 on all uses and applications of: cannabinoids as antioxidants and neuroprotectants.
     (c) In 2009, U.S. patent # 8632825 was issued for cannabis oil use in the treatment of cancer.
     (d) In 2012, Washington state voters approved the possession and sale of twenty-eight grams of cannabis for adults twenty-one years and older.

     (2) The legislature finds that cannabis has medicinal properties and the attitude about it has changed, therefore qualifying patients need to have compassion and truly safe access to their medicine. The legislature intends to ensure the protection of qualifying patients, health care professionals, and designated providers by:

     (a) Creating the Washington state cannabis regulation commission with a cannabis for medical use board to create a not-for-profit business model that is the cannabis for medical use market. The mission is to provide the highest quality medicine to the patients at the lowest price possible for qualifying patients who need it the most;

     
(b) Creating an application fee, an annual fee for insurance and renewal of licenses, and regulation fees on cannabis for medical use that are managed by the cannabis for medical use board to use in conjunction with other funds in the dedicated cannabis for medical use account to keep the regulation of the cannabis for medical use market by the board revenue neutral.
     (c) Protecting access for patients to cannabis for medical use by preserving the intent of Initiative Measure No. 692 while creating the regulation intended with Engrossed Substitute Senate Bill No. 5073, yet vetoed out, using the bipartisan language previously approved by a bipartisan legislature specifying cannabis for medical use licensing, as well as other protections from it to qualifying patients;

     (d) Restoring the original definition of a sixty-day supply that the department of health determined for the legislatur
e;
     (e) Protecting qualifying patients under eighteen years of age, parents, legal guardians, and his or her designated provide
r;
     (f) Allowing cannabis to be used as a botanical herb for qualifying patients exempting it from taxation;
and
     (g) Requiring proof of impairment for qualifying patients for driving while under the influence laws of Washington state.

     (3) Therefore, the legislature further strengthens reform to chapter 69.51A RCW of Washington state by enacting changes.
Comments